Literature DB >> 1477320

Eosinophilia and cellular cytokine responsiveness in hemodialysis patients.

J Hertel1, P L Kimmel, T M Phillips, J P Bosch.   

Abstract

Eosinophilia in hemodialysis (HD) patients has been associated with allergy to dialyzers and exaggerated activation of complement during HD. Its etiology, however, remains unknown. Complement activation can lead to cytokine production, and interleukin-2 (IL-2) administration has been shown to cause eosinophilia. Because abnormalities in cellular cytokine production in renal patients were previously demonstrated, the relationship between dialysis-associated eosinophilia and IL production in this HD population was studied. Twelve patients on chronic HD therapy with normal eosinophil counts (mean, 0.23 +/- 0.03 cells/nL) were compared with nine patients with eosinophilia (mean, 0.85 +/- 0.17 cells/nL). Measurements of cellular IL-1 and IL-2 production were performed before (pre) and after (post) HD with cuprammonium dialyzers. In patients with eosinophilia, stimulated cellular IL-1 production increased by 117 +/- 40% (P < 0.01) when post-HD measurements were compared with pre-HD values and IL-2 production increased by 127 +/- 65% (P < 0.05). In contrast, there was no difference in stimulated cellular cytokine production when values before and after HD were compared in patients without eosinophilia. Individual responses were reproducible during subsequent dialysis. It was concluded that cellular cytokine production in response to HD is not uniform. Eosinophilia is a clinically useful marker of exaggerated HD-associated cytokine production. Cytokine production depends on individual responsiveness and is probably related to atopy.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1477320     DOI: 10.1681/ASN.V361244

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  4 in total

1.  Association between absolute blood eosinophil count and CKD stages among cardiac patients.

Authors:  Rui Ishii; Shu-Ichi Fujita; Shun Kizawa; Kazushi Sakane; Hideaki Morita; Michishige Ozeki; Koichi Sohmiya; Masaaki Hoshiga; Nobukazu Ishizaka
Journal:  Heart Vessels       Date:  2014-10-18       Impact factor: 2.037

2.  Immunologic function and survival in hemodialysis patients.

Authors:  P L Kimmel; T M Phillips; S J Simmens; R A Peterson; K L Weihs; S Alleyne; I Cruz; J A Yanovski; J H Veis
Journal:  Kidney Int       Date:  1998-07       Impact factor: 10.612

3.  Eosinophil count and mortality risk in incident hemodialysis patients.

Authors:  Duk-Hee Kang; Yuji Lee; Carola Ellen Kleine; Yong Kyu Lee; Christina Park; Jui-Ting Hsiung; Connie M Rhee; Csaba P Kovesdy; Kamyar Kalantar-Zadeh; Elani Streja
Journal:  Nephrol Dial Transplant       Date:  2020-06-01       Impact factor: 5.992

4.  Idiopathic hypereosinophilic syndrome in hemodialysis patients: Case reports.

Authors:  Yuko Mutsuyoshi; Keiji Hirai; Junki Morino; Shohei Kaneko; Saori Minato; Katsunori Yanai; Hiroki Ishii; Momoko Matsuyama; Taisuke Kitano; Akinori Aomatsu; Haruhisa Miyazawa; Kiyonori Ito; Yuichiro Ueda; Susumu Ookawara; Yoshiyuki Morishita
Journal:  Medicine (Baltimore)       Date:  2021-03-12       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.